American Heart Journal
Volume 148, Issue 3 , Pages 405-415 , September 2004

Clinical significance of a single measurement of troponin-I and C-reactive protein at admission in 1773 consecutive patients with acute coronary syndromes

  • Luigi Oltrona, MD

      Affiliations

    • Dipartimento Cardiotoracovascolare A. De Gasperis, Ospedale Niguarda, Milano, Italy
    • ,
  • Filippo Ottani, MD

      Affiliations

    • Divisione di Cardiologia, Ospedale S. Bortolo, Vicenza and Fondazione Cardiologica Sacco, Forlì, Italy
    • ,
  • Marcello Galvani, MD

      Affiliations

    • Divisione di Cardiologia, Ospedale G.B. Morgagni and Fondazione Cardiologica Sacco, Forlì, Italy
    • Corresponding Author InformationReprint requests: Marcello Galvani, MD, Fondazione Cardiologica Sacco, Piazza F.lli Ruffini, 6, 47100 Forlì, Italy.
    • ,
  • on behalf of the Italian Working Group on Atherosclerosis, Thrombosis, and Vascular Biology and the Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO)

Received 5 October 2003 ,Accepted 26 March 2004.

References 

  1. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. www.acc.org. Accessed January 20, 2004
  2. Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology . Management of acute coronary syndromes in patients presenting without ST-segment elevation. Eur Heart J. 2002;23:1809–1840
  3. Ottani F, Galvani M, Nicolini FA, et al.  Elevated cardiac troponin levels predict the risk of adverse outcome in patients with ACS. Am Heart J. 2000;140:917–927
  4. Lindahl B, Toss H, Siegbahn A, et al.  Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary disease. N Engl J Med. 2000;343:1139–1147
  5. Mueller C, Buettner HJ, Hodgson JM, et al.  Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation. 2002;105:1412–1415
  6. 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations. Circulation1999;100:1016–30
  7. Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology . Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2003;24:28–66
  8. Morrow DA, Rifai N, Tanasijevic MJ, et al.  Clinical efficacy of three assays for cTnI for risk stratification in ACS (a thrombolysis in myocardial infarction (TIMI) 11B substudy). Clin Chem. 2000;46:453–460
  9. Antman EM, Tanasijevic MJ, Thompson B, et al.  Cardiac-specific cTnI levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335:1342–1349
  10. Ohman EM, Armstrong PW, Christenson RH, et al.  Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med. 1996;335:1333–1342
  11. Stubbs P, Collins P, Moseley D, et al.  Prognostic significance of admission troponin T concentrations in patients with myocardial infarction. Circulation. 1996;94:1291–1297
  12. Liuzzo G, Biasucci LM, Gallimore R, et al.  The prognostic value of CRP and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994;33:417–424
  13. Sabatine MS, Morrow DA, de Lemos JA, et al.  Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes (simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide). Circulation. 2002;105:1760–1763
  14. Morrow DA, Rifai N, Antman EM, et al.  CRP is a potent predictor of mortality independently of and in combination with troponin T in ACS (a TIMI 11A substudy). J Am Coll Cardiol. 1998;31:1460–1465
  15. James SK, Armstrong P, Barnathan E, et al.  Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome (a GUSTO-IV substudy). J Am Coll Cardiol. 2003;41:916–924
  16. Kaul P, Fu Y, Chang WC, et al.  PARAGON-A and GUSTO-IIb Investigators   Prognostic value of ST-segment depression in acute coronary syndromes (insights from PARAGON-A applied to GUSTO-IIb). J Am Coll Cardiol. 2001;38:64–71
  17. Holmvang L, Clemmensen P, Lindahl B, et al.  Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment. J Am Coll Cardiol. 2003;41:905–915
  18. Kaul P, Newby K, Fu Y, et al.  Troponin T and quantitative ST-segment depression offer complimentary prognostic information in the risk stratification of acute coronary syndrome patients. J Am Coll Cardiol. 2003;41:371–380
  19. Antman E, Bassand JP, Klein W, et al.  Myocardial infarction redefined (a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction: the Joint European Society of Cardiology/American College of Cardiology Committee). Eur Heart J. 2000;35:959–969
  20. de Winter RJ, Fischer JC, de Jongh T, et al.  Different time frames for the occurrence of elevated levels of cardiac troponin T and CRP in patients with acute myocardial infarction. Clin Chem Lab Med. 2000;38:1151–1153
  21. Oldgren J, Siegbahn A, Wallentin L. Reversal of C-reactive protein but not fibrinogen elevation in unstable coronary artery disease. Eur Heart J. 2001;22:1301
  22. Ohman EM, Armstrong PW, White HD, et al.  Gusto-III Investigators   Risk stratification with a point-of-cardiac troponin-T test in acute myocardial infarction. Am J Cardiol. 1999;84:1281–1286
  23. Matetzky S, Sharir T, Domingo M, et al.  Elevated troponin I level on admission is associated with adverse outcome of primary angioplasty in acute myocardial infarction. Circulation. 2000;102:1611–1616
  24. Giannitsis E, Lehrke S, Wiegand UKH, et al.  Risk stratification in patients with inferior acute myocardial infarction treated by percutaneous coronary interventions (the role of admission troponin I). Circulation. 2000;102:2038–2044
  25. Morrow DA, Antman EM, Charlesworth A, et al.  TIMI risk score for ST-elevation myocardial infarction (a convenient, bedside clinical score for risk assessment at presentation: an intravenous nPA for treatment of infracting myocardium early II trial substudy). Circulation. 2000;102:2031–2037
  26. De Lemos JA, Morrow DA, Bentley JH, et al.  The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001;345:1014–1021
  27. Omland T, Persson A, Ng L, et al.  N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation. 2002;106:2913–2918
  28. Galvani M, Ottani F, Oltrona L, et al.  N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. J Am Coll Cardiol. 2003;41:402A
  29. Antman EM, Cohen M, Bernink PJ, et al.  The TIMI risk score for unstable angina/non-ST elevation MI (a method for prognostication and therapeutic decision making). JAMA. 2000;284:835–842
  30. Khot UN, Jia G, Moliterno DJ, et al.  Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes. JAMA. 2003;290:2174–2182

PII: S0002-8703(04)00149-8

doi: 10.1016/j.ahj.2004.03.023

American Heart Journal
Volume 148, Issue 3 , Pages 405-415 , September 2004

Article Tools

* Image Usage & Resolution